Orthopaedic insoles, reviewed for diabetic foot ulcer preventionPhoto: Luca Cascianini / <a href="https://commons.wikimedia.org/wiki/File:Insoles-Plantillas-Plantari.jpg">Wikimedia Commons</a>, CC BY-SA 4.0

Orthopaedic insoles reliably reduce plantar pressure in people with diabetic neuropathy, but the evidence that they prevent foot ulcers rests largely on a single study from India, according to a systematic review published on 9 November in the Journal of Clinical Medicine.

The review was carried out by seven researchers from the University of Valencia and Complutense University of Madrid, including José Luis Lázaro-Martínez of the Complutense diabetic foot unit. They searched PubMed, Embase and Web of Science for studies in people with diabetes and neuropathy but no active ulcer, comparing foot orthoses with no orthoses or with other insole designs. Thirteen studies met the criteria, from 963 records.

Orthopaedic insoles and pressure: consistent reductions

Across the included studies, orthoses reduced pressure most clearly beneath the metatarsal heads, the most common site of neuropathic ulceration. Findings included:

  • Reductions of 50% to 76% with custom insoles in therapeutic footwear, rising to 85% at sites of previous ulceration (Arts et al.).
  • A 46% reduction with insoles of optimal stiffness compared with no insole, and reductions of 28% to 50%, depending on site, in a later trial of seven insoles of different stiffness (Chatzistergos et al.).
  • Retrocapital bars reducing forefoot pressure in several studies, although not significantly in all.
  • A 32% reduction at two weeks and 28% at six months with custom orthoses, an effect that was no longer statistically significant at one year (Lobmann et al.).

Newer designs are entering the evidence base, including 3D-printed insoles and insoles made from modular materials selected by artificial intelligence, each tested in small repeated-measures studies published in 2026.

Ulcers: one study

Only one included study followed participants prospectively for ulceration. Viswanathan and colleagues, from Chennai, published in Diabetes Care in 2004, followed 241 people for nine months. Ulcers developed in 33% of those who wore their own footwear without orthoses, compared with 3% to 4% of those given insoles made from materials including microcellular rubber, polyurethane foam, EVA and cork, with custom-made insoles for people with deformities.

The authors conclude that foot orthoses “may contribute” to ulcer prevention by reducing pressure in high-risk areas, but that longitudinal studies are needed to show that lower pressure leads to fewer first and recurrent ulcers. They note that most included studies are more than a decade old, overall quality is moderate, only two were prospective, and adherence and cost-effectiveness were not examined. The review was not registered and received no external funding.

IMEA POD Perspective

For pedorthists and podiatrists in India and the wider region, the most striking point is that the strongest outcome evidence in this review comes from Chennai and used locally available materials such as microcellular rubber. That supports the case for affordable, locally made insoles as a core part of diabetic foot prevention rather than a luxury. The review also shows that pressure reduction varies widely with design, stiffness and fit, so an insole is only as good as the assessment and manufacture behind it. Clinics that measure in-shoe pressure and record ulcer outcomes over time could help close the evidence gap the authors describe. Adherence, which the review did not examine, is the other challenge: as the Gulf DFU guidelines point out, barefoot walking at home is common in the region, and the best insole does nothing if it stays in the cupboard.

Sources and further reading

Leave a Reply